Dr Reddys Laboratories Share Price Today - Live Blog for November 04, 2025

With a -0.07% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,200.80. The stock is currently trading at a PE of 17.4000, while the industry PE is 34.6343, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,200.30. This remarkable performance has caught the eye of investors.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.02% in its share price, and it currently trades at ₹1,198.20 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.05%, a situation worth noting. At present, the stock is trading at ₹1,198.10. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.4000, while the industry PE ratio is 34.6343.

Dr Reddys Laboratories Ltd's stock price surged by 0.01%, reaching the current market value of ₹1,197.80 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd witnessed a -0.08% drop in its share price and is currently trading at ₹1,197.65. With the stock's PE at 17.4000 and the industry PE at 34.6343, investors are weighing their options.

Dr Reddys Laboratories Ltd's share price has dropped by -0.06%, a development that warrants careful analysis. Presently trading at ₹1,198.00, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's stock price surged by 0.00%, reaching the current market value of ₹1,198.75 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.02%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,197.80 per share.

Dr Reddys Laboratories Ltd displayed price stability, with no changes, and is trading at ₹1,198.40. While the stock's performance remains constant, it's worth noting that its PE ratio is 17.4000, while the industry PE is 34.6343.

Dr Reddys Laboratories Ltd's share price has fallen by -0.06%, a situation worth noting. At present, the stock is trading at ₹1,198.45. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.4000, while the industry PE ratio is 34.6343.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.03% gain, with the share price now at ₹1,198.65. Notably, the stock's PE ratio stands at 17.4000, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd share price surged by 0.03%. With its current market price standing at ₹1,198.30 per share, this stock is garnering increased attention from the investment community.

After a significant 0.20% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,198.05 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price remained unchanged, indicating a period of stability in the market. As of now, the stock is still trading at ₹1,195.70. This static phase might encourage investors to assess their long-term strategies.

Dr Reddys Laboratories Ltd's share price rallied by 0.16%, reaching the current market price of ₹1,195.80. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.02% drop, and it's now trading at ₹1,194.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a -0.11% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,194.70. The stock has a PE ratio of 17.4000, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, a situation worth noting. At present, the stock is trading at ₹1,194.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.4000, while the industry PE ratio is 34.6343.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, a situation worth noting. At present, the stock is trading at ₹1,194.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.4000, while the industry PE ratio is 34.6343.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.07%, reaching a current market price of ₹1,194.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd suffered a -0.07% decline, and it currently trades at ₹1,194.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.20%, signalling a challenging period. Currently trading at ₹1,195.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has dropped by -0.20%, a development that warrants careful analysis. Presently trading at ₹1,197.30, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.07%, signalling a challenging period. Currently trading at ₹1,199.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.21% boost, with the current market value at ₹1,199.00 per share. This surge has not gone unnoticed by investors.